Show simple item record

Autologous T cells with NY-ESO-1-specific T-cell receptor (GSK3377794) in HLA-A*02+previously-treated and -untreated advanced metastatic/unresectable synovial sarcoma: A master protocol study design

dc.contributor.authorD'Angelo, S
dc.contributor.authorBlay, JY
dc.contributor.authorChow, W
dc.contributor.authorDemetri, G
dc.contributor.authorThistlethwaite, Fiona C
dc.contributor.authorWagner, M
dc.contributor.authorLoeb, D
dc.contributor.authorAttia, S
dc.contributor.authorRazak, A
dc.contributor.authorHaanen, J
dc.contributor.authorHasan, A
dc.contributor.authorBilliard, J
dc.contributor.authorPearce, L
dc.contributor.authorWu, YH
dc.contributor.authorJi, R
dc.contributor.authorJohnson, L
dc.contributor.authorSrinath, C
dc.contributor.authorShalabi, A
dc.contributor.authorStrauss, S
dc.contributor.authorThornton, K
dc.contributor.authorMackall, C
dc.contributor.authorTap, W
dc.contributor.authorVan Tine, B
dc.date.accessioned2020-01-29T15:17:43Z
dc.date.available2020-01-29T15:17:43Z
dc.date.issued2019en
dc.identifier.citationD'Angelo S, Blay J, Chow W, Demetri G, Thistlethwaite FC, Wagner M, et al. Autologous T cells with NY-ESO-1-specific T-cell receptor (GSK3377794) in HLA-A*02+previously-treated and -untreated advanced metastatic/unresectable synovial sarcoma: A master protocol study design. Journal for Immunotherapy of Cancer. 2019;7en
dc.identifier.urihttp://hdl.handle.net/10541/622633
dc.language.isoenen
dc.titleAutologous T cells with NY-ESO-1-specific T-cell receptor (GSK3377794) in HLA-A*02+previously-treated and -untreated advanced metastatic/unresectable synovial sarcoma: A master protocol study designen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentMemorial Sloan Kettering Cancer Center, New York, NYen
dc.identifier.journalJournal for Immunotherapy of Canceren
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record